Skip to main content
Article thumbnail
Location of Repository

Chemotherapy alone for organ preservation in advanced laryngeal cancer

By Vasu Divi, Francis P. Worden, Mark E. Prince, Avraham Eisbruch, Julia S. Lee, Carol R. Bradford, Douglas B. Chepeha, Theodoros N. Teknos, Norman D. Hogikyan, Jeffrey S. Moyer, Christina I. Tsien, Susan G. Urba and Gregory T. Wolf


Background. For patients with advanced laryngeal cancer, a trial was designed to determine if chemotherapy alone, in patients achieving a complete histologic complete response after a single neoadjuvant cycle, was an effective treatment with less morbidity than concurrent chemoradiotherapy. Methods. Thirty-two patients with advanced laryngeal or hypopharyngeal cancer received 1 cycle of induction chemotherapy, and subsequent treatment was decided based on response. Results. A histologic complete response was achieved in 4 patients and were treated with chemotherapy alone. All 4 patients' cancer relapsed in the neck and required surgery and postoperative radiotherapy (RT). Twenty-five patients were treated with concomitant chemoradiation. Three patients were treated with surgery. Overall survival and disease-specific survival at 3 years were 68% and 78%, respectively. Conclusion. Chemotherapy alone is not feasible for long-term control of regional disease in patients with advanced laryngeal cancer even when they achieve a histologic complete response at the primary site. © 2009 Wiley Periodicals, Inc. Head Neck, 201

Publisher: Wiley Subscription Services, Inc., A Wiley Company
Year: 2010
DOI identifier: 10.1002/hed.21285
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.